Sullivan
Microsoft has discontinued support for Internet Explorer. To access the Sullivan website, please install a modern browser like Microsoft Edge or Google Chrome.
Crossing the Pacific: U.S. Capital Markets Opportunities for Taiwanese Biotech Companies
When: July 16, 2026 at 1:30 PM - 5:30 PM CST
Location: BIO Asia-Taiwan 2026
 

Taipei City, Taiwan

People: David E. Danovitch, Angela Gomes, Joseph E. Segilia and Jiayin Liao

In conjunction with BIO Asia-Taiwan 2026, Sullivan will host an executive roundtable and networking reception on July 16, 2026, in Taipei City, Taiwan, titled "Crossing the Pacific: U.S. Capital Markets Opportunities for Taiwanese Biotech Companies." Partners David Danovitch, Angela Gomes and Joseph Segilia and associate Jiayin Liao will each speak on topics related to the opportunities, challenges, and practical realities facing Taiwanese biotech companies seeking access to the U.S. capital markets.

The program will explore candid lessons from cross-border biotech IPOs, including strategic considerations surrounding U.S. listings, market expectations, valuation dynamics, regulatory issues, and the long-term implications of operating as a U.S.-listed company. The event is intended to foster substantive dialogue among biotech founders, CEOs, CFOs, investors, and cross-border advisors active in the life sciences sector.

For a detailed agenda, please visit our event page
 

Resources